NAVIDEA BIOPHARMACEUTICALS, INC. Contracts & Agreements

Navidea Biopharmaceuticals, Inc. 2023 Equity Incentive Plan (Filed With SEC on November 16, 2023)

Offer Letter between Navidea Biopharmaceuticals, Inc. and Craig Dais dated July 26, 2023 (Filed With SEC on July 28, 2023)

Second Amendment to Asset Purchase Agreement dated as of June 14, 2023 between Cardinal Health 414, LLC and Navidea Biopharmaceuticals, Inc (Filed With SEC on June 16, 2023)

Stock Exchange Agreement dated as of June 1, 2023 between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr (Filed With SEC on June 5, 2023)

Stock Purchase Agreement dated as of May 22, 2023 between Navidea Biopharmaceuticals, Inc. and Donald E. Garlikov (Filed With SEC on May 25, 2023)

Stock Purchase Agreement dated as of May 22, 2023 between Navidea Biopharmaceuticals, Inc. and Irwin Bain (Filed With SEC on May 25, 2023)

Common Stock Purchase Agreement dated as of April 26, 2023 between Navidea Biopharmaceuticals, Inc. and Keystone Capital Partners, LLC (Filed With SEC on April 28, 2023)

Registration Rights Agreement dated as of April 26, 2023 between Navidea Biopharmaceuticals, Inc. and Keystone Capital Partners, LLC (Filed With SEC on April 28, 2023)

Secured Bridge Note dated as of April 25, 2023 (Filed With SEC on April 28, 2023)

First Amendment to Security Agreement dated as of April 25, 2023 between Navidea Biopharmaceuticals, Inc. and John Kim Scott, Jr (Filed With SEC on April 28, 2023)

Asset Purchase Agreement dated as of April 10, 2023 between Navidea Biopharmaceuticals, Inc. and Meilleur Technologies, Inc (Filed With SEC on April 13, 2023)

Separation & Release Agreement effective March 30, 2023 between Navidea Biopharmaceuticals, Inc. and Michael Rosol (Filed With SEC on March 31, 2023)

Consulting Services Agreement effective March 30, 2023 between Navidea Biopharmaceuticals, Inc. and G2G Ventures (Filed With SEC on March 31, 2023)

First Amendment to Section 382 Rights Agreement dated as of January 10, 2023 between Navidea Biopharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, LLC (Filed With SEC on January 10, 2023)

Form of Dealer-Manager Agreement (Filed With SEC on August 2, 2022)

Certificate of Designations, Preferences and Rights of Series I Convertible Preferred Stock (Filed With SEC on August 2, 2022)

Form of Common Stock Purchase Warrant to be issued in rights offering (Filed With SEC on August 2, 2022)

Form of Warrant Agency Agreement between Navidea Biopharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, LLC (Filed With SEC on August 2, 2022)

Form of Subscription Rights Certificate (Filed With SEC on August 2, 2022)

Certificate of Designations, Preferences and Rights of Series I Convertible Preferred Stock (Filed With SEC on July 20, 2022)

Form of Common Stock Purchase Warrant to be issued in rights offering (Filed With SEC on July 20, 2022)

Form of Warrant Agency Agreement between Navidea Biopharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, LLC (Filed With SEC on July 20, 2022)

Form of Subscription Rights Certificate (Filed With SEC on July 20, 2022)

Section 382 Rights Agreement, dated as of April 7, 2022, between Navidea Biopharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, LLC, as Rights Agent (Filed With SEC on April 12, 2022)

Stock Exchange and Loan Agreement between Investor and Navidea Biopharmaceuticals, Inc., dated April 10, 2022 (Filed With SEC on April 12, 2022)

Secured Term Note, dated April 10, 2022 (Filed With SEC on April 12, 2022)

Security Agreement dated as of April 10, 2022 by Navidea Biopharmaceuticals, Inc. in favor of John Kim Scott, Jr (Filed With SEC on April 12, 2022)

Registration Rights Agreement effective as of April 10, 2022 by and between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr (Filed With SEC on April 12, 2022)

Separation Agreement and General Release between the Company and Jed A. Latkin (Filed With SEC on November 26, 2021)

Amendment to Stock Purchase Agreement and Letter of Investment Intent by and between the Company and Investor dated July 8, 2021 (Filed With SEC on July 13, 2021)

Stock Purchase Agreement and Letter of Investment Intent by and between the Company and Investor dated March 2, 2021 (Filed With SEC on March 4, 2021)

Registration Rights Agreement by and between the Company and Investor dated March 2, 2021 (Filed With SEC on March 4, 2021)

Stock Purchase Agreement and Letter of Investment Intent, by and between the Company and Keystone (Filed With SEC on September 2, 2020)

Form of Common Stock Purchase Agreement (Filed With SEC on September 2, 2020)

Amended and Restated Equity Commitment Letter, dated August 14, 2020, between Mastiff Group LLC and Navidea Biopharmaceuticals, Inc (Filed With SEC on August 14, 2020)

Stock Purchase Agreement, effective August 9, 2020, by and between Navidea Biopharmaceuticals, Inc. and Jubilant Radiopharma (Filed With SEC on August 12, 2020)

Employment Agreement, effective July 27, 2020, by and between Navidea Biopharmaceuticals, Inc. and Jed A. Latkin (Filed With SEC on July 31, 2020)

Stock Purchase Agreement and Letter of Investment Intent by and between the Company and the Investor (Filed With SEC on May 12, 2020)

Termination Agreement by and among the Company, SpePharm and Norgine (Filed With SEC on May 12, 2020)

Description of Securities (Filed With SEC on March 18, 2020)

Stock Purchase Agreement, effective February 14, 2020, by and between Navidea Biopharmaceuticals, Inc. and Keystone Capital Partners, LLC (Filed With SEC on March 18, 2020)

Stock Purchase Agreement, effective February 14, 2020, by and between Navidea Biopharmaceuticals, Inc. and John K. Scott (Filed With SEC on March 18, 2020)

Registration Rights Agreement, dated December 6, 2019, among Navidea Biopharmaceuticals, Inc. and the stockholders named therein (Filed With SEC on December 11, 2019)

Stock Purchase Agreement, dated December 6, 2019, among Navidea Biopharmaceuticals, Inc. and the purchasers named therein (Filed With SEC on December 11, 2019)

Underwriting Agreement, dated June 13, 2019, by and between Navidea Biopharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on June 17, 2019)

Form of Underwriter Warrants of Navidea Biopharmaceuticals, Inc (Filed With SEC on June 17, 2019)

Stock Purchase Agreement, dated March 22, 2019, between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr (Filed With SEC on May 9, 2019)

Agreement dated August 14, 2018, by and among Navidea Biopharmaceuticals, Inc., Macrophage Therapeutics, Inc. and Michael M. Goldberg, M.D (Filed With SEC on November 9, 2018)

Stock Purchase Agreement dated September 13, 2018, by and between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr (Filed With SEC on November 9, 2018)

Employment Agreement, effective October 1, 2018, by and between Navidea Biopharmaceuticals, Inc. and Jed A. Latkin (Filed With SEC on October 5, 2018)

Navidea Biopharmaceuticals, Inc. 2014 Stock Incentive Plan (as amended and restated on August 16, 2018) (Filed With SEC on August 21, 2018)

Amendment to Asset Purchase Agreement dated April 2, 2018 between Navidea Biopharmaceuticals, Inc. and Cardinal Health 414, LLC (Filed With SEC on May 9, 2018)

EMPLOYMENT AGREEMENT (Filed With SEC on May 10, 2017)

GLOBAL SETTLEMENT AGREEMENT (Filed With SEC on March 9, 2017)

LICENSE-BACK AGREEMENT (Filed With SEC on March 9, 2017)

WARRANT TO PURCHASE SHARES OF COMMONSTOCK (Filed With SEC on March 9, 2017)

AMENDED AND RESTATED LICENSE AGREEMENT BETWEEN NAVIDEA BIOPHARMACEUTICALS, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR CASE NO. SD1998-088 (Filed With SEC on March 9, 2017)

ASSET PURCHASE AGREEMENT by and between CARDINALHEALTH 414, LLC and NAVIDEABIOPHARMACEUTICALS, INC. Dated November 23, 2016 (Filed With SEC on November 30, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on September 27, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on May 10, 2016)

DIRECTOR AGREEMENT (Filed With SEC on May 10, 2016)

DIRECTOR AGREEMENT (Filed With SEC on March 29, 2016)

AGREEMENT (Filed With SEC on March 18, 2016)

AMENDMENT1 TO TERM LOAN AGREEMENT (Filed With SEC on January 11, 2016)

TERM LOAN AGREEMENT dated as of May 8, 2015 between NavideaBiopharmaceuticals, Inc. as Borrower, The SUBSIDIARY GUARANTORS from Time toTime Party Hereto, and Capital Royalty... (Filed With SEC on October 9, 2015)

SECURITIES EXCHANGE AGREEMENT (Filed With SEC on August 26, 2015)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF NavideaBiopharmaceuticals, Inc. Expires _______, 2035 (Filed With SEC on August 26, 2015)

The EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2015)

TERM LOAN AGREEMENT dated as of May 8, 2015 between NavideaBiopharmaceuticals, Inc. as Borrower, The SUBSIDIARY GUARANTORS from Time toTime Party Hereto, and Capital Royalty... (Filed With SEC on May 21, 2015)

SECURITYAGREEMENT (Filed With SEC on May 15, 2015)

SUBORDINATIONAGREEMENT (Filed With SEC on May 15, 2015)

THIRD AMENDMENT TO LOAN AGREEMENT (Filed With SEC on May 15, 2015)

THIRD AMENDED AND RESTATED PROMISSORY NOTE (Term Loan Facility) (Filed With SEC on May 15, 2015)

NAVIDEA BIOPHARMACEUTICALS, INC. 2014 Stock Incentive Plan (as amended March 3, 2015) Article I Establishment, Purpose, Duration (Filed With SEC on May 11, 2015)

SECURITIES EXCHANGE AGREEMENT (Filed With SEC on May 11, 2015)

AGREEMENT BETWEEN NAVIDEA BIOPHARMACEUTICALS, INC. AND ALSERES PHARMACEUTICALS, INC. (Filed With SEC on April 27, 2015)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 11, 2015)

SECURITIES EXCHANGE AGREEMENT (Filed With SEC on November 13, 2014)

NAVIDEA BIOPHARMACEUTICALS, INC. 5600 Blazer Parkway, Suite 200, Dublin, Ohio 43017-7550 Date_of_Grant Employee Address CityState (Filed With SEC on November 10, 2014)

NAVIDEA BIOPHARMACEUTICALS, INC. 2014 STOCK INCENTIVE PLAN RESTRICTED STOCK AWARD GRANT NOTICE AND RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on November 10, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on October 15, 2014)

NAVIDEA BIOPHARMACEUTICALS, INC. 5600 Blazer Parkway, Suite 200Dublin,Ohio 43017-7550 (Filed With SEC on October 15, 2014)

AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on August 11, 2014)

TERMINATION OF LICENSE AGREEMENT UCSD CONTROL #2008-03-0536 (Filed With SEC on August 11, 2014)

LICENSE AGREEMENT (Filed With SEC on August 11, 2014)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 11, 2014)

SUBORDINATION AGREEMENT (Filed With SEC on August 11, 2014)

R-NAV, LLC SERIES A PREFERRED UNIT PURCHASE AGREEMENT (Filed With SEC on July 16, 2014)

PROMISSORY NOTE (Filed With SEC on July 16, 2014)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on June 2, 2014)

CONSULTING AGREEMENT (Filed With SEC on June 2, 2014)

EMPLOYMENT AGREEMENT II (Filed With SEC on April 24, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on April 24, 2014)

LOAN AND SECURITY AGREEMENT (Filed With SEC on March 7, 2014)

SUBORDINATION AGREEMENT (Filed With SEC on March 7, 2014)

SECOND AMENDMENT TO LOAN AGREEMENT (Filed With SEC on March 7, 2014)

SECOND AMENDED AND RESTATED PROMISSORYNOTE (Term Loan Facility) (Filed With SEC on March 7, 2014)

WARRANT TO PURCHASE STOCK (Filed With SEC on March 7, 2014)

DIRECTOR AGREEMENT (Filed With SEC on November 19, 2013)

FORM OF WARRANT NAVIDIA BIOPHARMACEUTICALS, INC. WarrantTo Purchase Common Stock (Filed With SEC on September 24, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 24, 2013)

[Remainder of the pageintentionally left blank.] (Filed With SEC on September 24, 2013)

MANUFACTURING SERVICES AGREEMENT (Filed With SEC on September 12, 2013)

OFFICE LEASE (Filed With SEC on September 5, 2013)

MANUFACTURING SERVICESAGREEMENT Between NavideaBiopharmaceuticals, Inc. And PETNETSolutions, Inc. (Filed With SEC on August 22, 2013)

LOAN ANDSECURITY AGREEMENT (Filed With SEC on June 28, 2013)

WARRANT (Filed With SEC on June 28, 2013)

AMENDMENT TO LOAN AGREEMENT (Filed With SEC on June 28, 2013)

SUBORDINATION AGREEMENT (Filed With SEC on June 28, 2013)

AMENDED AND RESTATED PROMISSORYNOTE (TermLoan Facility) (Filed With SEC on June 28, 2013)

WARRANT EXERCISE AGREEMENT (Filed With SEC on June 28, 2013)

NAVIDEA BIOPHARMACEUTICALS, INC. AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS,VOTING POWERS, PREFERENCES, LIMITATIONS, RESTRICTIONS,AND RELATIVE RIGHTS OF SERIES B CONVERTIBLE... (Filed With SEC on June 26, 2013)

CERTIFICATE OF ELIMINATION OF NAVIDEA BIOPHARMACEUTICALS, INC. (Filed With SEC on June 26, 2013)

[123I]NAV5001 Clinical SupplyAgreement THIS AGREEMENT made in duplicate as of this10th day of May, 2013 (Filed With SEC on May 16, 2013)

2,100,000 Shares NAVIDEA BIOPHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 24, 2013)

1,542,389 Shares NAVIDEA BIOPHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 31, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on January 7, 2013)

SCHEDULE IDENTIFYING MATERIAL DIFFERENCESBETWEEN EMPLOYMENT AGREEMENTS BETWEEN NAVIDEA BIOPHARMACEUTICALS, INC.AND THE INDIVIDUALS LISTED BELOW (Filed With SEC on January 7, 2013)

AMENDMENT TO SERIES X WARRANT (Filed With SEC on December 19, 2012)

NAVIDEA BIOPHARMACEUTICALS, INC. 425 Metro Place North, Suite 450 Dublin, Ohio 43017 December 13, 2012 (Filed With SEC on December 19, 2012)

SECURITIES EXCHANGE AGREEMENT (Filed With SEC on December 3, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on September 6, 2012)

SUBLICENSE AGREEMENT By and Between ALSERES PHARMACEUTICALS, INC. and NAVIDEA BIOPHPARMACEUTICALS, INC. (Filed With SEC on August 6, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 6, 2012)

LOAN AGREEMENT dated as of July 25, 2012 BETWEEN Navidea Biopharmaceuticals, Inc., As Borrower and Platinum-Montaur Life Sciences LLC, As Lender (Filed With SEC on July 31, 2012)

PROMISSORY NOTE (TermLoan Facility) (Filed With SEC on July 31, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on June 7, 2012)

OUT-LICENCE AGREEMENT by and between ASTRAZENECA AB and NEOPROBE CORPORATION DATE: 9 DECEMBER 2011 (Filed With SEC on April 11, 2012)

SCHEDULE IDENTIFYING MATERIAL DIFFERENCESBETWEEN EMPLOYMENT AGREEMENTS BETWEEN NAVIDEA BIOPHARMACEUTICALS, INC.AND THE INDIVIDUALS LISTED BELOW (Filed With SEC on March 7, 2012)

LOAN AND SECURITY AGREEMENT (Filed With SEC on January 5, 2012)

WARRANT TO PURCHASE COMMON STOCK OF NEOPROBE CORPORATION ISSUED ON DECEMBER 29, 2011 VOID AFTER 5:30 P.M., PACIFIC TIME, ON DECEMBER 29, 2016 (Filed With SEC on January 5, 2012)

OUT-LICENCE AGREEMENT by and between ASTRAZENECA AB and NEOPROBE CORPORATION DATE: 9 DECEMBER 2011 (Filed With SEC on December 15, 2011)

NEOPROBE CORPORATION THIRD AMENDED AND RESTATED 2002 STOCK INCENTIVE PLAN (Filed With SEC on August 17, 2011)

By:/s/ Mark J. PykettMark J. PykettPresident and Chief Executive Officer (Filed With SEC on August 4, 2011)

Exhibit 10.1EMPLOYMENT AGREEMENT (Filed With SEC on June 6, 2011)

SETTLEMENT AGREEMENT (Filed With SEC on April 18, 2011)

Exhibit 10.1SEPARATION AGREEMENT AND RELEASE (Filed With SEC on April 1, 2011)

CONSULTING AGREEMENT (Filed With SEC on April 1, 2011)

Exhibit 10.3 EMPLOYMENT AGREEMENT (Filed With SEC on April 1, 2011)

Exhibit 10.4 RELOCATION AGREEMENT (Filed With SEC on April 1, 2011)

NEOPROBE CORPORATION THIRD AMENDED AND RESTATED 2002 STOCK INCENTIVE PLAN (Filed With SEC on March 16, 2011)

EMPLOYMENTAGREEMENT (Filed With SEC on December 27, 2010)

SCHEDULEIDENTIFYING MATERIAL DIFFERENCES BETWEEN EMPLOYMENTAGREEMENTS BETWEENNEOPROBE CORPORATION AND THEINDIVIDUALS LISTED BELOW (Filed With SEC on December 27, 2010)

Rodman& Renshaw, LLC 1251 Avenue of the Americas, 20th Floor,New York, NY 10020 Tel ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on November 12, 2010)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on November 12, 2010)

SERIESCC COMMON STOCK PURCHASE WARRANT NEOPROBECORPORATION (Filed With SEC on November 12, 2010)

SERIESDD COMMON STOCK PURCHASE WARRANT NEOPROBECORPORATION (Filed With SEC on November 12, 2010)

SERIESEE COMMON STOCK PURCHASE WARRANT NEOPROBECORPORATION (Filed With SEC on November 12, 2010)

MANUFACTURE AND SUPPLYAGREEMENT (Filed With SEC on August 10, 2010)

NEOPROBECORPORATION CERTIFICATEOF DESIGNATIONS, VOTING POWERS, PREFERENCES,LIMITATIONS, RESTRICTIONS, AND RELATIVE RIGHTSOF SERIES B CONVERTIBLE PREFERRED STOCK (Filed With SEC on June 28, 2010)

NEOPROBECORPORATION CERTIFICATEOF DESIGNATIONS, VOTING POWERS, PREFERENCES,LIMITATIONS, RESTRICTIONS, AND RELATIVE RIGHTSOF SERIES C CONVERTIBLE PREFERRED STOCK (Filed With SEC on June 28, 2010)

SECURITIESEXCHANGE AGREEMENT (Filed With SEC on June 28, 2010)

EMPLOYMENTAGREEMENT (Filed With SEC on February 26, 2010)

EMPLOYMENTAGREEMENT (Filed With SEC on January 6, 2010)

FIFTHAMENDMENT TO REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 22, 2009)

NEOPROBECORPORATION SECONDAMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS, VOTINGPOWERS, PREFERENCES, LIMITATIONS, RESTRICTIONS,AND RELATIVE RIGHTS OF SERIES A 8%... (Filed With SEC on July 29, 2009)

SECURITIESAMENDMENT AND EXCHANGE AGREEMENT (Filed With SEC on July 29, 2009)

NEOPROBECORPORATION Amendedand Restated 10% Series A Senior Secured Convertible PromissoryNote dueDecember 26, 2011 (Filed With SEC on July 29, 2009)

NEOPROBECORPORATION Amendedand Restated 10% Series B Senior Secured Convertible PromissoryNote dueDecember 26, 2011 (Filed With SEC on July 29, 2009)

AMENDEDAND RESTATED SERIES W WARRANT TO PURCHASE SHARES OFCOMMON STOCK OF NEOPROBECORPORATION ExpiresDecember 26, 2012 (Filed With SEC on July 29, 2009)

AMENDEDAND RESTATED SERIES X WARRANT TO PURCHASE SHARES OFCOMMON STOCK OF NEOPROBECORPORATION ExpiresApril 16, 2013 (Filed With SEC on July 29, 2009)

AMENDEDAND RESTATED SERIES Y WARRANT TO PURCHASE SHARES OFCOMMON STOCK OF NEOPROBECORPORATION ExpiresDecember 5, 2013 (Filed With SEC on July 29, 2009)

SERIES AAWARRANT TO PURCHASE SHARES OFCOMMON STOCK OF NEOPROBECORPORATION ExpiresJuly 24, 2014 (Filed With SEC on July 29, 2009)

Exhibit4.1 NEOPROBECORPORATION FIRSTAMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS, VOTINGPOWERS, PREFERENCES, LIMITATIONS, RESTRICTIONS,AND RELATIVE RIGHTS OF SERIES A 8%... (Filed With SEC on May 6, 2009)

Exhibit10.1 Platinum-MontaurLife Sciences, LLC 152 West57thStreet New York,New York 10019 (Filed With SEC on April 6, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on February 17, 2009)

FIRST AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on December 31, 2008)

FORM OF EMPLOYMENT AGREEMENT (Filed With SEC on December 23, 2008)

FOURTH AMENDMENT TO REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 9, 2008)

SERIES Y WARRANT TO PURCHASE (Filed With SEC on December 9, 2008)

THIRD AMENDMENT TO REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 24, 2008)

NEOPROBE CORPORATION SECOND AMENDED AND RESTATED 2002 STOCK INCENTIVE PLAN (Filed With SEC on June 27, 2008)

AMENDMENT AND WAIVER FOR SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 18, 2008)

SECOND AMENDMENT TO REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 18, 2008)

NEOPROBE CORPORATION (Filed With SEC on April 18, 2008)

SERIES X WARRANT TO PURCHASE SHARES OF COMMON STOCK OF NEOPROBE CORPORATION Expires April 16, 2013 No.: WX 08-001 Number of Shares: 8,333,333Date of Issuance: April 16, 2008 (Filed With SEC on April 18, 2008)

NEOPROBE CORPORATION (Filed With SEC on April 18, 2008)

Entry Into a Material Definitive Agreement (Filed With SEC on January 9, 2008)

NEOPROBE CORPORATION (Filed With SEC on January 2, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 2, 2008)

NEOPROBE CORPORATION (Filed With SEC on January 2, 2008)

No. $ 3,000,000.00 Dated: [ ], 2008 (Filed With SEC on January 2, 2008)

SERIES W WARRANT TO PURCHASE (Filed With SEC on January 2, 2008)

FORM OF SERIES X WARRANT TO PURCHASE (Filed With SEC on January 2, 2008)

FORM OF SERIES Y WARRANT TO PURCHASE (Filed With SEC on January 2, 2008)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 2, 2008)

SECURITY AGREEMENT (Filed With SEC on January 2, 2008)

PATENT, TRADEMARK (Filed With SEC on January 2, 2008)

NEOPROBE CORPORATION (Filed With SEC on January 2, 2008)

SECURITY AGREEMENT (Filed With SEC on January 2, 2008)

SERIES WV07 WARRANT TO PURCHASENO. 007 500,000 SHARES OF COMMON STOCK (Filed With SEC on January 2, 2008)

FIRST AMENDMENT TO DISTRIBUTION AGREEMENT (Filed With SEC on December 20, 2007)

SUPPLY AND DISTRIBUTION AGREEMENT (Filed With SEC on November 21, 2007)

10% CONVERTIBLE NOTE PURCHASE AGREEMENT NEOPROBE CORPORATION (Filed With SEC on July 9, 2007)

NEOPROBE CORPORATION 10% CONVERTIBLE NOTE DUE JULY 8, 2008 $1,000,000.00 July 3, 2007 (Filed With SEC on July 9, 2007)

SERIES WV07 WARRANT TO PURCHASE NO. 001 500,000SHARES OF COMMON STOCK WARRANT TO PURCHASE COMMON STOCK OF NEOPROBE CORPORATION (Filed With SEC on July 9, 2007)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 9, 2007)

EMPLOYMENT AGREEMENT (Filed With SEC on January 5, 2007)

SCHEDULE IDENTIFYING MATERIAL DIFFERENCES BETWEEN EMPLOYMENT AGREEMENTS EFFECTIVE JANUARY 1, 2007 BETWEEN NEOPROBE CORPORATION AND THE INDIVIDUALS LISTED BELOW (Filed With SEC on January 5, 2007)

NEOPROBE CORPORATION Suite 300 425 Metro Place North Dublin, Ohio 43017-1367 [Date of Grant] [Employee] [Address] [City/State] (Filed With SEC on December 21, 2006)

AMENDMENT TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 4, 2006)

[FORM OF REPLACEMENT NOTE] (Filed With SEC on December 4, 2006)

[FORM OF REPLACEMENT WARRANT] (Filed With SEC on December 4, 2006)

SCHEDULE IDENTIFYING OMITTED DOCUMENTS (Filed With SEC on December 4, 2006)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on December 4, 2006)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 4, 2006)

Category

Industry

Companies

Contracts

NAVIDEA BIOPHARMACEUTICALS, INC. Contracts & Agreements